Coronavirus Clash: Global Pharma Scrambles In Locking Down World
Managing Change In Unprecedented Crisis
A former pharma executive shares views with Scrip about the coronavirus in China, the challenges facing corporations and individuals in a rapidly changing world and coming threats that could potentially cause even more damage than the pandemic.
You may also be interested in...
When a global pandemic hits and local rules over personal movement are highly fluid and constantly updated, two pharma firms with a global footprint have faced unprecedented tests.
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
As China is poised to supply medical products to fight the coronavirus around the world, a battle to banish its image of poor product quality is on.